Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Maintenance ElectroConvulsive Therapy in Clozapine RESISTant Schizophrenia - the MECT-RESIST Trial

NCT06456983 is registered in ClinicalTrials.gov with Central Institute of Mental Health, Mannheim as lead sponsor.

NCT NCT06456983
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06456983 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Maintenance ElectroConvulsive Therapy in Clozapine RESISTant Schizophrenia - the MECT-RESIST Trial
Lead sponsor
Central Institute of Mental Health, Mannheim
Phase
Not applicable
Overall status
Recruiting
Start date
February 14, 2025
Completion date
July 31, 2028
Enrollment
140 (estimated)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

schizophrenia, treatment resistant schizophrenia